Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis

• Guang-Qian Xiao ,

  * E-mail: guang-qian_xiao@urmc.rochester.edu

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Pamela Unger,

  Affiliation Departments of Pathology, Lenox Hill Hospital, New York, New York, United States of America

  ⨯
• Qi Yang,

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Yayoi Kinoshita,

  Affiliation Departments of Pathology, Mount Sinai Medical Center, New York, New York, United States of America

  ⨯
• Kyra Singh,

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Loralee McMahon,

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Kent Nastiuk,

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Kai Sha,

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• John Krolewski,

  Affiliation Departments of Pathology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• David Burstein

  Affiliation Departments of Pathology, Mount Sinai Medical Center, New York, New York, United States of America

  ⨯